#11: CVBT News CardioVascular BioTherapeutics to Present at 2006 Money Show in London; Co-Founder to Discuss Outlook for New Treatment for Cardiovascular Disease
LAS VEGAS--(BUSINESS WIRE)--Sept. 19, 2006--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) announced that Daniel C. Montano, president and CEO, is presenting the progress of the company's drug...
#10: CVBT News CardioVascular BioTherapeutics Announces Clinical Collaboration with Dr. Vance Gardner and the Orthopaedic Education and Research Institute of Southern California
LAS VEGAS and ORANGE, Calif.--(BUSINESS WIRE)--Sept. 13, 2006-- Researchers to Conduct Feasibility Study for Treatment Potential of Cardio Vascu-Grow(TM) in Patients with Chronic Back Pain...
#9: CVBT News CardioVascular BioTherapeutics to Present at 2006 UBS Life Sciences Conference; President and CEO to Discuss Protein Drug Candidate to Treat Cardiovascular Disease
LAS VEGAS--(BUSINESS WIRE)--Sept. 12, 2006--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) today announced that Daniel C. Montano, President and CEO is presenting the progress of the company's...
LAS VEGAS--(BUSINESS WIRE)--Sept. 7, 2006--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) today announced it has signed a master service agreement with leading global clinical research...
#7: CVBT News CardioVascular BioTherapeutics Engages The Bruckner Group to Evaluate Healthcare Value Proposition of Drug Candidates; CVBT to Work With Healthcare Value Strategy Experts to Develop Plan to Obtain Broad Payer Coverage
LAS VEGAS--(BUSINESS WIRE)--Sept. 6, 2006--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) today announced that it has engaged The Bruckner Group (BGI) to help develop the value proposition for...
LAS VEGAS--(BUSINESS WIRE)--Aug. 22, 2006--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) today announced that Co-Founder and Chief Clinical Officer Dr. Thomas Stegmann will present the keynote...
LAS VEGAS & CINCINNATI--(BUSINESS WIRE)--Aug. 17, 2006-- "No Option Heart Patients" Participated in Cardio Vascu-Grow Phase I Clinical Trial for Innovative Protein Therapy to Stimulate Growth...
#4: CVBT News CardioVascular BioTherapeutics to Present at 2006 Money Show; Co-Founder to Discuss Treatment Options for Different Types of Cardiovascular Disease
LAS VEGAS--(BUSINESS WIRE)--July 13, 2006--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) announced that Daniel C. Montano, president and CEO, is presenting the progress of the company's drug...
#3: CVBT News CardioVascular BioTherapeutics to Present at Fourth Annual Emerging Technologies Symposium; World Renowned Cardiac & Thoracic Surgeon to Discuss New Treatment for No-Option Heart Patients
LAS VEGAS--(BUSINESS WIRE)--July 6, 2006--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) today announced that Co-Founder and Chief Clinical Officer, Dr. Thomas Stegmann, the cardiac surgeon who...
#2: CVBT News CardioVascular BioTherapeutics Co-Founder to Present Seminar on New Treatment for Heart Disease; Renowned Cardiac & Thoracic Surgeon Dr. Thomas Stegmann to Introduce Novel Protein Drug Candidate
LAS VEGAS--(BUSINESS WIRE)--July 5, 2006--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) today announced that its Chief Clinical Officer, Dr. Thomas J. Stegmann, will present the keynote address...
#1: CVBT News CardioVascular BioTherapeutics Inc. Hires Schwartz Communications for Corporate and Product Communications; Leading PR Firm Selected to Build Awareness of Novel Therapy for Cardiovascular Disease
LAS VEGAS--(BUSINESS WIRE)--June 22, 2006--CardioVascular BioTherapeutics Inc. (OTCBB:CVBT) today announced that it has engaged Schwartz Communications Inc. (Waltham, Mass., and San Francisco,...
